{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:20:43Z","timestamp":1790619643789,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.thromres.2024.109115","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:32:26Z","timestamp":1723627946000},"page":"109115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors"],"prefix":"10.1016","volume":"242","author":[{"given":"Luciana Werneck","family":"Zuccherato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renan Pedra","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Mesquita","family":"Camelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maise Moreira","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Lemos","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Ant\u00f4nio Portugal","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Gon\u00e7alves","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Santos","family":"Lorenzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Hermida","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Karla Brognoli","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosangela de Albuquerque","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leina Yukari","family":"Etto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria do Rosario Ferraz","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bia Michelle de Ara\u00fajo","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aline Ferreira","family":"de Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieda Solange de Souza","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Aparecida","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Hissa","family":"Anegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Campos Fontes","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doralice Marvulle","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Pereira","family":"Tou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Gon\u00e7alves","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"van der Bom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Meireles","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.109115_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1056\/NEJM199401063300108","volume":"330","author":"Hoyer","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.109115_bb0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2024.109115_bb0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.thromres.2024.109115_bb0020","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/hmg\/2.11.1773","article-title":"Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions","volume":"2","author":"Naylor","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.thromres.2024.109115_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2516.2011.02700.x","article-title":"F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race\/ethnicity","volume":"18","author":"Miller","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jtha.2022.12.029","article-title":"Hemophilia treatment innovation: 50 years of progress and more to come","volume":"21","author":"Mannucci","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/hae.14638","article-title":"Management of haemophilia A with inhibitors: a regional cross-talk","volume":"28","author":"Peyvandi","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ejh.13193","article-title":"Inhibitors in haemophilia A and B: management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients","volume":"102","author":"Ljung","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2024.109115_bb0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2024.109115_bb0050","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1053\/j.seminhematol.2008.03.004","article-title":"Arthropathy in inhibitor patients: differences in the joint status","volume":"45","author":"Hoots","year":"2008","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.thromres.2024.109115_bb0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.blre.2018.02.003","article-title":"Review of immune tolerance induction in hemophilia A","volume":"32","author":"Schep","year":"2018","journal-title":"Blood Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2024.109115_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hae.13445","article-title":"Immune tolerance induction: what have we learned over time?","volume":"24","author":"Brackmann","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0065","article-title":"Determinants of successful immune tolerance induction in hemophilia a: systematic review and meta-analysis. Res Pract","volume":"7","author":"Oomen","year":"2023","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0070","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1538-7836.2009.03615.x","article-title":"Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors","volume":"7","author":"Coppola","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/hae.14431","article-title":"Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors","volume":"28","author":"Di Minno","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2516.2007.01437.x","article-title":"F8 gene mutation profile and ITT response in a cohort of Italian haemophilia a patients with inhibitors","volume":"13","author":"Salviato","year":"2007","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2024.109115_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","article-title":"Genetic diagnosis of haemophilia and other inherited bleeding disorders","volume":"12","author":"Peyvandi","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256265","article-title":"Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: the Brazilian Immune Tolerance (BrazIT) Study protocol","volume":"16","author":"Camelo","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2024.109115_bb0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MBC.0000000000001057","article-title":"Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study","volume":"32","author":"Jardim","year":"2021","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2024.109115_bb0100","series-title":"Tem\u00e1tica ed. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade","article-title":"Imunotoler\u00e2ncia: protocolo de uso de indu\u00e7\u00e3o de imunotoler\u00e2ncia para pacientes com hemofilia A e inibidor","author":"Minist\u00e9rio da Sa\u00fade","year":"2015"},{"key":"10.1016\/j.thromres.2024.109115_bb0105","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2024.109115_bb0110","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1111\/jth.15878","article-title":"Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study","volume":"20","author":"Camelo","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0115","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.109115_bb0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12730","article-title":"International Immune Tolerance Induction Study I. US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors","volume":"21","author":"Valentino","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2516.2010.02392.x","article-title":"Detection of int1h-related inversion of the factor VIII gene","volume":"17","author":"Pio","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1538-7836.2008.02926.x","article-title":"Developing a new generation of tests for genotyping hemophilia-causative rearrangements involving int22h and int1h hotspots in the factor VIII gene","volume":"6","author":"Rossetti","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.thromres.2024.109115_bb0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.thromres.2024.109115_bb0145","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"Gouw","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2024.109115_bb0150","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.284095","article-title":"Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children","author":"Andersson","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2024.109115_bb0155","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1365-2516.2010.02272.x","article-title":"Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A","volume":"16","author":"van Helden","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/jth.12846","article-title":"Anti-A2 and anti-A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A","volume":"13","author":"Lapalud","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109115_bb0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2516.2007.01620.x","article-title":"The use of factor VIII\/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile","volume":"14","author":"Greninger","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0049-3848(02)00352-3","article-title":"Epitope specificity of anti-FVIII antibodies during immune tolerance therapy with factor VIII preparation containing von Willebrand factor","volume":"107","author":"Kallas","year":"2002","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.109115_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2516.2010.02226.x","article-title":"Role of anti-idiotypic antibodies in immune tolerance induction","volume":"16","author":"Gilles","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2024.109115_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12824","article-title":"Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: type of factor 8 mutation and outcomes","volume":"6","author":"Sun","year":"2022","journal-title":"Res Pract Thromb Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:29:22Z","timestamp":1725668962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":36,"alternative-id":["S0049384824002470"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109115","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109115"}}